Literature DB >> 26680683

Ultraviolet Keratitis: From the Pathophysiological Basis to Prevention and Clinical Management.

Gabriel Willmann1,2.   

Abstract

Ultraviolet keratitis is caused by the toxic effects of acute high-dose ultraviolet radiation (UVR) reflecting the sensitivity of the ocular surface to photochemical injury. The clinical syndrome presents with ocular pain, tearing, conjunctival chemosis, blepharospasm, and deterioration of vision typically several hours after exposure, lasting up to 3 days. Mountaineers, skiers, and beach recreationalists are particularly at risk to suffer from ultraviolet (UV) keratitis as the reflectivity of UVR in these environments is extremely high. The aim of this review is to raise awareness about the potential of UV damage on the eye with an emphasis on UV keratitis, to highlight the pathophysiological basis of corneal phototoxicity, and to provide practical guidance for the prevention and clinical management of UV keratitis commonly known as snow blindness.

Entities:  

Keywords:  cornea; high altitude; keratitis solaris; snow blindness; ultraviolet keratitis

Mesh:

Year:  2015        PMID: 26680683     DOI: 10.1089/ham.2015.0109

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  14 in total

Review 1.  Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Authors:  Y Q Soh; Viridiana Kocaba; Mauricio Pinto; Jodhbir S Mehta
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

2.  Autophagy mediates cell cycle response by regulating nucleocytoplasmic transport of PAX6 in limbal stem cells under ultraviolet-A stress.

Authors:  Maria Laggner; Andreas Pollreisz; Gerald Schmidinger; Ursula Schmidt-Erfurth; Ying-Ting Chen
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

3.  UVB promotes the initiation of uveitic inflammatory injury in vivo and is attenuated by UV-blocking protection.

Authors:  Yi-Ching Shao; Jyh-Cheng Liou; Chan-Yen Kuo; Yun-Shan Tsai; En-Chieh Lin; Ching-Ju Hsieh; Si-Ping Lin; Bo-Yie Chen
Journal:  Mol Vis       Date:  2017-04-12       Impact factor: 2.367

4.  Reversible Brain Abnormalities in People Without Signs of Mountain Sickness During High-Altitude Exposure.

Authors:  Cunxiu Fan; Yuhua Zhao; Qian Yu; Wu Yin; Haipeng Liu; Jianzhong Lin; Tianhe Yang; Ming Fan; Luobu Gesang; Jiaxing Zhang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 5.  Photokeratitis induced by ultraviolet radiation in travelers: A major health problem.

Authors:  M Izadi; N Jonaidi-Jafari; M Pourazizi; M H Alemzadeh-Ansari; M J Hoseinpourfard
Journal:  J Postgrad Med       Date:  2018 Jan-Mar       Impact factor: 1.476

6.  UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation.

Authors:  M Notara; S Behboudifard; M A Kluth; C Maßlo; C Ganss; M H Frank; B Schumacher; C Cursiefen
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

7.  Protective Effects of Fucoxanthin on Ultraviolet B-Induced Corneal Denervation and Inflammatory Pain in a Rat Model.

Authors:  Shiu-Jau Chen; Ching-Ju Lee; Tzer-Bin Lin; Hsien-Yu Peng; Hsiang-Jui Liu; Yu-Shan Chen; Kuang-Wen Tseng
Journal:  Mar Drugs       Date:  2019-03-05       Impact factor: 5.118

8.  Increased photokeratitis during the coronavirus disease 2019 pandemic: Clinical and epidemiological features and preventive measures.

Authors:  YingMing Wang; Jing Lou; Ye Ji; ZhenYu Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

Review 9.  Differentiating Urgent and Emergent Causes of Acute Red Eye for the Emergency Physician.

Authors:  Christopher J Gilani; Allen Yang; Marc Yonkers; Megan Boysen-Osborn
Journal:  West J Emerg Med       Date:  2017-03-03

10.  Biomechanical Modulation Therapy-A Stem Cell Therapy Without Stem Cells for the Treatment of Severe Ocular Burns.

Authors:  Ricardo M Gouveia; Che J Connon
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.